Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 1282

Forward-looking: The service department can seem like the slowest part of a dealership, especially when it’s your car getting worked on. But Mercedes-Benz is infusing its dealerships with AR technology to speed up the diagnosis and repair of tricky and complex issues with its Virtual Remote Support, powered by Microsoft’s HoloLens 2 and Dynamics 365 Remote Assist. I visited one of Mercedes’ showcases last week to check out the implementation and get some hands-on time with the HoloLens 2.

For customers that bring in a hard-to-solve problem, it was common for Mercedes-Benz to call in a flying doctor, an expert from HQ that would fly in and get hands-on with an issue. That could take days to arrange, not to mention the costs and environmental impacts associated with flying in these technical specialists from all over the country. All the while, the customer is left without their luxury automobile.

While many shoppers go with a Mercedes for the styling and performance, it’s the service experience that impacts their future purchases. Long waits could see someone changing brands in the future.

Read more | >

Integrated And Cross-Disciplinary Research Focused on Diagnosing, Treating And Curing Cancers — Dr. Antonio Giordano MD, PhD, President & Founder, Sbarro Health Research Organization.

Dr. Antonio Giordano, MD, Ph.D., (https://www.drantoniogiordano.com/) is President and Founder of the Sbarro Health Research Organization (https://www.shro.org/), which conducts research to diagnose, treat and cure cancer, but also has diversified into research beyond oncology, into the areas of cardiovascular disease, diabetes and other chronic illnesses.

Dr. Giordano is also a Professor of Molecular Biology at Temple University in Philadelphia, a ‘Chiara fama’ Professor in the Department of Pathology & Oncology at the University of Siena, Italy, and Director of the Sbarro Institute for Cancer Research and Molecular Medicine, and the Center for Biotechnology, at Temple’s College of Science & Technology.

Continue reading “Dr. Antonio Giordano, MD, Ph.D. — President and Founder, Sbarro Health Research Organization” | >

Interview with a very important researcher who gives a reality check on a few things (Sirtuins) and explains how effective Rapamycin has been.

Professor Matt Kaeberlein discusses aspects of aging and proposed interventions to improve health. He gives an in-depth review on sirtuins, resveratrol, fasting, NAD precursors, and rapamycin.

Timestamps.

Continue reading “Resveratrol, Fasting, & Rapamycin | Matt Kaeberlein” | >

The central principle of superconductivity is that electrons form pairs. But can they also condense into foursomes? Recent findings have suggested they can, and a physicist at KTH Royal Institute of Technology today published the first experimental evidence of this quadrupling effect and the mechanism by which this state of matter occurs.

Reporting in Nature Physics, Professor Egor Babaev and collaborators presented evidence of fermion quadrupling in a series of experimental measurements on the iron-based material, Ba1−xKxFe2As2. The results follow nearly 20 years after Babaev first predicted this kind of phenomenon, and eight years after he published a paper predicting that it could occur in the material.

The pairing of electrons enables the quantum state of superconductivity, a zero-resistance state of conductivity which is used in MRI scanners and quantum computing. It occurs within a material as a result of two electrons bonding rather than repelling each other, as they would in a vacuum. The phenomenon was first described in a theory by, Leon Cooper, John Bardeen and John Schrieffer, whose work was awarded the Nobel Prize in 1972.

Read more | >

For most of the time since the first description of multiple sclerosis (MS) in 1,868 the causes of this disabling disease have remained uncertain. Genes have been identified as important, which is why having other family members with MS is associated with a greater risk of developing the disease.

A recent study my colleagues and I conducted found that several types of infection during the teenage years are associated with MS after age 20. Our study didn’t investigate whether people who are more likely to have genetic risks for MS were also more likely to have worse infections.

This might explain why people with MS also have more infections that need hospital treatment.

Read more | >

If the properties of materials can be reliably predicted, then the process of developing new products for a huge range of industries can be streamlined and accelerated. In a study published in Advanced Intelligent Systems, researchers from The University of Tokyo Institute of Industrial Science used core-loss spectroscopy to determine the properties of organic molecules using machine learning.

The spectroscopy techniques energy loss near-edge structure (ELNES) and X-ray near-edge structure (XANES) are used to determine information about the electrons, and through that the atoms, in materials. They have high sensitivity and high resolution and have been used to investigate a range of materials from electronic devices to drug delivery systems.

However, connecting spectral data to the properties of a material—things like optical properties, electron conductivity, density, and stability—remains ambiguous. Machine learning (ML) approaches have been used to extract information for large complex sets of data. Such approaches use artificial neural networks, which are based on how our brains work, to constantly learn to solve problems. Although the group previously used ELNES/XANES spectra and ML to find out information about materials, what they found did not relate to the properties of the material itself. Therefore, the information could not be easily translated into developments.

Read more | >

Conventional lung cancer treatments include surgery, chemotherapy and radiotherapy; however, these treatments are often poorly tolerated by patients. Cannabinoids have been studied for use as a primary cancer treatment. Cannabinoids, which are chemically similar to our own body’s endocannabinoids, can interact with signalling pathways to control the fate of cells, including cancer cells. We present a patient who declined conventional lung cancer treatment. Without the knowledge of her clinicians, she chose to self-administer ‘cannabidiol (CBD) oil’ orally 2–3 times daily. Serial imaging shows that her cancer reduced in size progressively from 41 mm to 10 mm over a period of 2.5 years. Previous studies have failed to agree on the usefulness of cannabinoids as a cancer treatment. This case appears to demonstrate a possible benefit of ‘CBD oil’ intake that may have resulted in the observed tumour regression. The use of cannabinoids as a potential cancer treatment justifies further research.

Read more | >